Canada markets open in 55 minutes

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.00050.0000 (0.00%)
As of 07:00AM CET. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 133.07k
Enterprise Value 1.42M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.39
Price/Book (mrq)N/A
Enterprise Value/Revenue 19.31
Enterprise Value/EBITDA -0.73

Trading Information

Stock Price History

Beta (5Y Monthly) 1.41
52-Week Change 30.00%
S&P500 52-Week Change 327.69%
52 Week High 30.0240
52 Week Low 30.0005
50-Day Moving Average 30.0005
200-Day Moving Average 30.0010

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 538.91M
Implied Shares Outstanding 6265.71M
Float 838.68M
% Held by Insiders 113.74%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:200
Last Split Date 3Apr 20, 2018

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends May 31, 2022
Most Recent Quarter (mrq)Feb 28, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)831.74%

Management Effectiveness

Return on Assets (ttm)-69.60%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)73.48k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.03M
Net Income Avi to Common (ttm)-3.36M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.81k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.9M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.11
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-1.4M
Levered Free Cash Flow (ttm)-612.49k